Human health is tightly connected with a great number of gut microbial cells designated as microbiome or microbiota. We have examined the effect of six microbial strains (MS) included in a commercial probiotic on cytokine production by human peripheral blood mononuclear cells (PBMC) and on their immune dialog with colon carcinoma cells. Non-stimulated and lipopolysaccharide (LPS)-stimulated PBMC were incubated for 24 h with MS. The secretion of tumor necrosis factor alpha (TNFα), IL-1β, IL-6, interferon gamma, IL-10 and IL-1ra and the effect of MS on the immune interplay between PBMC and cells from HT-29 and RKO colon carcinoma lines were evaluated. MS incubated with non-stimulated PBMC induced high expression of all cytokines examined, whereas in those stimulated by LPS, variability in the results was observed. MS added to PBMC co-cultivated with HT-29 or RKO colon cancer cells resulted in downregulation of most cytokines except IL-6 and TNFα, and enhanced production of TNFα and IL-1β. The MS incorporated in the probiotic affected PBMC' cytokine production and altered the cross-talk between immune and colon cancer cells. The results may clarify the way by which probiotics modify the intestinal environment resulting in a decline of colon cancer development.
INTRODUCTION
The human body and particularly the gastrointestinal tract contain a silent, health-sustaining partner represented by a variety of microbial communities designated as microbiota or referred by some authors as microbiome. The term microbiota is used to define the microorganisms in the environment applying 16S ribosomal RNA, while microbiome comprises genes and genomes, as well as the products of the microbial and host environment (Gill et al. 2006; Whiteside et al. 2015) . Although there is a difference in definition, these terms are used conjointly. With improvement of culture conditions, researchers' attention has been progressively drawn to the importance of microbiome for the function of many systems. Since the microbiome is nested in various organs, but mainly in the gastrointestinal tract (Gill et al. 2006; Pandey, Naik and Vakil 2015) , this health collaborator plays at normal composition a major role in metabolic and immune responses of the human organism (Perdigon et al. 1995; Greenhalgh et al. 2016) . On the other hand, any change of microbiome components may lead to serious complications including cancer development (Pevsner-Fischer et al. 2016) . Age, genetics, various diets, drugs and the state of the innate and adaptive immunity are factors that may amend the normal state of human intestinal microbiome and alter immune homeostasis in ways recently reviewed by Tuddenham and Sears (2015) . According to Cénit et al. (2014) , intestinal macrophages are phenotypically distinct from circulating monocytes, a difference characterized by reduced level of their innate responses and particularly by their sluggish production of proinflammatory cytokines in response to inflammatory processes. In addition, microbiota is actively engaged in the adaptive immune homeostasis by its capacity to initiate the immune response of CD4+T cells. It is not wonder, therefore, that the number of diseases, either immune or metabolic, linked with intestinal microbiome in particular and with microbiota in general is rapidly increasing (Coudeyras and Forestier 2010) .
The use of probiotics for prevention and treatment of acuteonset diarrhea has been recently assessed (Guandalini 2011; Rodes et al. 2013 ). It appears that the beneficial results following probiotics' administration were statistically significant, although modest from clinical point of view. In any case they were strain and dose dependent.
The relationship between gut microbiota and colon cancer development seems to be firmly established (Bultman 2016) . Zackular et al. (2013) have reported that germ-free mice colonized with microbiota from colon carcinoma bearing mice showed an increased colon tumorigenesis. Moreover, transfer of microbiota from these animals to conventional ones induced an increased population of microbiota associated with tumor formation. It is of interest that administration of antibiotics to affected mice reduced both tumor size and number.
Regarding the close relationship between chronic inflammation and cancer growth, it is plausible that probiotics may attenuate cancer development and progress by preventing inflammatory processes. This possibility brings to focus the effect of probiotics on the immune system and mainly on the function of peripheral blood mononuclear cells (PBMC). A detailed review as for the way probiotics enhance the immune system has been published by Ashraf and Shah (2014) . They emphasize that the most known probiotics from the Lactobacillus and Bifidobacterium families have the capacity to activate macrophages, NK cells and T-lymphocytes and to stimulate the generation of a series of cytokines. You and Yaqoob (2012) have exposed PBMC from healthy volunteers to the probiotic Bifidobacterium longum and have compared its effect on cytokine production with that of three commercial probiotics. The results showed that all of them activated NK cells and stimulated anti-inflammatory cytokine release. However, their immune effect diminished with aging. Working with six probiotic strains incubated separately with PBMC from healthy subjects, Dong, Rowland and Yaqoob (2012) have found that while all probiotics increased the production of IL-1β, IL-6, IL-10, TNF-α and granulocyte-macrophage colony stimulating factor, they did not affect the release of IL-2, IL-4, IL-5 and TNF-β. Moreover, various probiotic strains activated differently the immune function of PBMC, as has been observed in a study with RAW 264.7 macrophages (Rodes et al. 2013) , and in vivo with mice (Ren et al. 2015) and piglets (Kandasamy et al. 2016) .
While most commercial probiotic supplements contain more than one bacterium, it is remarkable that the majority of studies on the effect of probiotics on cytokine production have been carried out with individual strains. Therefore, our aim in the present work was to evaluate the effect of six probiotic strains incorporated in one commercial preparation on cytokine production by human non-stimulated and lipopolysaccharide (LPS)-stimulated PBMC and their effect on the dialog between immune and colon cancer cells.
MATERIALS AND METHODS
Co-Biotic (Lapidot Medical, Caesarea, Israel) was obtained as lyophilized mixture containing a total of 4.5×10 7 bacteria/mg. were added to 2×10 6 PBMC/ml giving bacteria to cell ratios of: 2.5:1, 5:1 and 10:1, respectively.
Cell preparation
PBMC were obtained from venous blood withdrawn from adult blood donors after signing an informed consent. The cells were separated by Lymphoprep-1077 (Axis-Shield PoC AS, Oslo, Norway) gradient centrifugation. They were washed twice in PBS and suspended in RPMI-1640 medium (Biological Industries, Beith Haemek, Israel) containing 10% heat inactivated fetal calf serum, and was designated as complete medium (CM).
Colon cancer cell lines
HT-29 and RKO human colon cancer cell lines were obtained from American Type Cultural Collection, Rockville, MD. The cells were maintained in CM containing Mc-COY'S 5A medium and modified eagle medium (MEM. Biological Industries Co), supplemented with 10% newborn calf serum, 2 mM L-glutamine and antibiotics (penicillin, streptomycin and nystatin; Biological Industries Co). The cells were grown in T-75 culture flasks at 37
• C in a humidified atmosphere containing 5% CO 2 .
Effect of MS on cytokine production
A total of 0.5 ml of PBMC (4×106/ml of CM) was incubated with an equal volume of CM without or with 40 ng/ml LPS (Escherichia coli, Sigma) or with 0.5 ml of HT-29 or RKO colon cancer cell lines (4×10 5 /ml of CM) suspended in appropriate CM. MS were added at the onset of cultures at a volume of 10 μl/ml. Control cultures contained CM only. The cultures were kept for 24 h at 37
• C in a humidified atmosphere containing 5% CO 2 . At the end of the incubation period, the cells were removed by centrifugation at 450 g for 10 min., the supernatants were collected and kept at -70
• C until assayed for cytokines content.
Cytokine content in the supernatants
The concentration of the following cytokines, TNFα, IL-1β, IL-6, IFNγ , IL-10 and IL-1ra in the supernatants, was tested using ELISA kits specific for these cytokines (Biosource International, Camarillo, CA) as detailed in the guideline provided by the manufacturer. The detection levels of these kits were 15 pg/ml for IL-6 and 30 pg/ml for the remaining cytokines.
Statistics
A linear mixed model with repeated measures and the assumption of compound symmetry was used to assess the effects of Table 1 . Effect of MS on the production of proinflammatory cytokines by PBMC TNFα, ng/ml (n = 7) IL-1β, ng/ml (n = 7) IL-6, ng/ml (n = 7) IFNγ , ng/ml (n = 7)
Bacteria/PBMC ratio Mean±SEM * P M e a n ±SEM * P M e a n ±SEM * P M e a n ±SEM * P 
RESULTS

Cytokine production by MS
No detectable levels of any of the cytokines tested in the current study could be found in supernatants collected from MS incubated for 24 h at concentrations of 0.5×10 7 /ml, 1×10 7 /ml or 2×10 7 /ml.
Effect of MS on cytokine secretion by HT-29 or RKO cells
Twenty four hours of incubation of HT-29 or RKO cells without or with MS at the concentrations applied did not reveal detectable amounts of any cytokine in the supernatants. (Table 1) Non-stimulated PBMC Incubation of non-stimulated PBMC with MS revealed impressive and significant increased production of TNFα, IL-1β, IL-6 and IFNγ (P < 0.005, Table 1 ). At MS to PBMC ratio of 2.5:1, the secretion of TNFα, IL-1β, IL-6 and IFNγ was 5.5, 4.4, 2.55 and 2.4 times enhanced compared to PBMC incubated without MS (P < 0.001 and P < 0.05). At elevated ratios of bacteria to PBMC, the increased production of cytokines was similar or even higher.
Effect of MS on proinflammatory cytokine secretion
LPS-induced cytokine production
The production of TNFα, IL-1β, and IFNγ by LPS-stimulated PBMC was significantly increased following incubation with MS (P < 0.001), while the secretion of IL-6 was dose-dependently reduced (P < 0.001). At MS to PBMC ratio of 2.5:1, the production of TNFα, IL-1β and IFNγ was stimulated by 59%, 63% and 127% (P < 0.005), respectively, whereas at ratios of 2.5:1, 5:1 and 10:1, the secretion of IL-6 was reduced by 19% (P = 0.058), 29% (P < 0.02) and 39% (P < 0.002), respectively.
HT-29-induced cytokine production
The secretion of TNFα and IL-6 by PBMC induced by HT-29 colon cancer cells was not affected following incubation with MS at the ratios indicated (P > 0.1), whereas that of IL-1β and IFNγ was slightly reduced (P < 0.005). At MS to PBMC ratio of 5:1, the secretion of IL-1β and IFNγ induced by HT-29 cells was inhibited by 16% (P < 0.03) and 26% (P < 0.01), respectively.
RKO-induced cytokine production
The production IFNγ by PBMC induced by RKO colon cancer cells was not affected by incubation with MS at the ratios indicated (P > 0.1). The production of TNFα and IL-1β was slightly enhanced (P = 0.0138 and P < 0.001, respectively) at the lower ratios of MS to PBMC (by 39% and 30%, respectively, P < 0.001), whereas that of IL-6 was reduced (P < 0.001) at and the higher ratio only (by 17%, P < 0.005).
Effect of MS on anti-inflammatory cytokine secretion (Table 2)
The secretion of IL-10 and IL-1ra by non-stimulated PBMC was enhanced when cells were incubated with increased ratios of MS PBMC were incubated for 24 h without (spontaneous) or with LPS or colon cancer cells (HT-29 or RKO) in the absence (0) or the presence of MS at ratios of bacteria to PBMC as indicated. The level of cytokines in the supernatants was tested by ELISA. The results are expressed as mean ± SEM of number of experiments as indicated. * P value represents statistically significant difference from cells incubated without MS. NS, not statistically significant.
(P < 0.001). However, MS caused a reduced secretion of IL-10 and IL-1ra when PBMC were stimulated by either LPS (P < 0.001), HT-29 cells (P < 0.001) or RKO cells (P < 0.001). At MS to PBMC ratio of 2.5:1, 5:1 and 10:1, the secretion of IL-10 by non-stimulated cells was 3.0, 2.85 and 2.26 times higher than that of cells incubated without MS, respectively (P < 0.02), and that of IL-1ra was enhanced by 55%, 47% and 40%, respectively (P < 0.03). Maximal inhibition of both IL-10 and IL-1ra production by stimulated PBMC was observed at bacteria to PBMC ratio of 10:1. At this ratio, IL-10 and IL-1ra production by LPS-stimulated PBMC was inhibited by 55% and 32% (P < 0.005), respectively, that induced by HT-29 cells was lowered by 30% and 26% (P < 0.01), respectively, and that induced by RKO cells was reduced by 43% and 23% (P < 0.02), respectively.
DISCUSSION
The present results show that the MS used in the study strongly prompted unstimulated PBMC to generate all cytokines examined, except for IL-1ra whose production was only slightly increased. The results became diverse when LPS-induced PBMC were incubated with MS: TNFα, IL-1β and IFNγ were noticeably stimulated, while the generation of IL-6, IL-1ra and IL-10 was decreased, the later, dose dependently. Shyu, Oyong and Cabrera (2014) have reported that macrophages exposed to Lactobacillus spp. supernatants showed downregulation of IL-1β and TNFα that differed from the one obtained from LPS-induced macrophages. The effect of lactic acid bacteria on the capacity of LPS-induced macrophages to produce cytokines has been previously observed. Jang et al. (2014) have found that a strain of Lactobacillus plantarum, i.e. CLP-0611, was able to downregulate the expression of IL-6 and IL-1β, whereas Lactobacillus spp. inhibited IL-1β and TNFα by LPS-stimulated mouse peritoneal macrophages (Shyu, Oyong and Cabrera 2014) . Mouse splenocytes treated with L. casei BL 23 showed increased generation of IL-6, IL-17, IL-10 and TGF-β (Lenoir et al. 2016) . Feeding whey sensitized mice with a probiotic containing L. acidophilus and Bifidobacterium bifidum resulted in suppressed serum level of IgE and decreased IL-4 generation by cultured splenocytes. On the other hand, the production of IFN-γ , IL-12 and IL-10 was increased (Shandilya et al. 2016) . Mice fed with three strains of lactic acid bacteria induced a significant increase of the phagocytic activity of both leukocytes and peritoneal macrophages and their splenocytes produced higher amounts of IFNγ compared with controls (Gill et al. 2000) . The linkage between chronic inflammation and alteration of gut tract microbiota has drawn attention. Jurjus et al. (2015) have reviewed the causes for co-occurrence of inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus, and concluded that dysbiosis induces chronic inflammation with increased migration of macrophages to the affected sites, imbalance of signaling pathways and upregulation of inflammatory and tumor promoting cytokines such as IL-6, IL-1α and TNFα. The relationship between chronic inflammation and carcinogenesis has been firmly established. Therefore, it is conceivable to assume that suppression of the inflammatory process by probiotics would slow down cancer development. In that sense, probiotics can act by recuperation of normal microbiota (Ambalam et al. 2016) , enhancing macrophages' phagocytic activity (Kapila et al. 2012) , and by regulation of the immune responses of the organism (Shyu, Oyong and Cabrera 2014) . Lactobacillus casei BL23 administered orally to mice with dimethylhydrazine-induced colorectal cancer resulted in colonic expression of IL-22 and by higher production of IL-6, IL-17, IL-10 and TGF-β by their splenocytes (Lenoir et al. 2016) . In this study, the addition of MS to PBMC incubated with colon carcinoma cells from the two lines showed that the probiotic altered the interplay between immune and malignant cells (Fig. 1) . In the presence of MS, PBMC co-incubated with HT-29 cells showed a decrease in most cytokines examined, although to various extents, while TNFα and IL-6 were not affected. When the same experiment was carried out with RKO cells, the generation of TNFα and IL-1β increased, whereas that of IL-6, IL-1ra and IL-10 was inhibited at high bacteria to cell ratio. One may argue that in the present work the use of a probiotic containing six MS may present a limitation. It has been shown that each individual bacterium may induce the production of specific cytokines, as has been mentioned in other studies (Shyu, Oyong and Cabrera 2014; Lenoir et al. 2016; Li et al. 2016) . However, the aim of the study was to examine the effect of all strains incorporated in one probiotic preparation. A similar approach has been reported by Li et al. (2016) , who have fed mice with hepatocellular carcinoma with a probiotic containing 10 probiotic strains and have found a significant decrease in tumor size and weight. In addition, splenocytes from probiotic fed mice showed a decrease in Th17 cells number with a downregulation of IL-17. The importance of this kind of studies is in clarifying the way by which probiotics interfere with immune balance between immune and cancer cells.
In short, probiotics are intensely involved in regulation of autoimmunity and prevention of an array of diseases including malignancies (Cénit et al. 2014; Jurjus et al. 2015; Reid 2016 ). It appears that probiotic strains, and particularly those within the gastrointestinal tract, are actively engaged in maintaining human health in an extent that perhaps is not fully appreciated presently.
